Physician profile
Christopher E Cenac
NPI 1609849413
$2,435.56
in general payments reported to CMS, 2019-2025
15 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $219 · 2021: $332 · 2022: $188 · 2023: $77.82 · 2024: $1,198 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $989 · Food and Beverage: $474.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $988.96 |
| Food and Beverage | $473.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zavation Medical Products, LLC | $1,261.61 | 2024-2025 | |
| Providence Medical Technology, INC. | $248.51 | 2021 | |
| Innovasis INC | $227.08 | 2020-2021 | |
| Precision Spine, INC. | $144.25 | 2019 | |
| Carlsmed, INC. | $134.51 | 2022 | |
| Stryker Corporation | $131.07 | 2019-2020 | |
| Centinel Spine, LLC | $81.29 | 2023-2024 | Prodisc L |
| Innovation Technologies INC | $45.25 | 2024-2025 | Irrisept |
| Seaspine Orthopedics Corporation | $38.04 | 2022 | |
| Medtronic, INC. | $34.32 | 2025 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Si-Bone, INC. | $23.70 | 2024 | |
| Baudax Bio INC. | $22.25 | 2021 | |
| Intrinsic Therapeutics | $16.41 | 2023 | Barricaid Acd (Annular Closure Device) |
| Smith+Nephew, INC. | $15.25 | 2022 | |
| Pacira Therapeutics, INC. | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Cenac listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.